Distinct loiasis infection states and associated clinical and hematological manifestations in patients from Gabon

Luzia Veletzky, Kirsten Alexandra Eberhardt, Jennifer Hergeth, Daniel Robert Stelzl, Rella Zoleko Manego, Ghyslain Mombo-Ngoma, Ruth Kreuzmair, Gerrit Burger, Ayôla Akim Adegnika, Selidji Todagbe Agnandji, Pierre Blaise Matsiegui, Michel Boussinesq, Benjamin Mordmüller, Michael Ramharter, Luzia Veletzky, Kirsten Alexandra Eberhardt, Jennifer Hergeth, Daniel Robert Stelzl, Rella Zoleko Manego, Ghyslain Mombo-Ngoma, Ruth Kreuzmair, Gerrit Burger, Ayôla Akim Adegnika, Selidji Todagbe Agnandji, Pierre Blaise Matsiegui, Michel Boussinesq, Benjamin Mordmüller, Michael Ramharter

Abstract

Background: Loiasis-a filarial disease endemic in Central and West Africa-is increasingly recognized as significant individual and public health concern. While the understanding of the disease characteristics remains limited, significant morbidity and excess mortality have been demonstrated. Here, we characterize clinical and hematological findings in a large cohort from Gabon.

Methods: Loiasis-related clinical manifestations and microfilaremia, hemoglobin and differential blood counts were recorded prospectively during a cross-sectional survey. For analysis, participants were categorized into distinct infection states by the diagnostic criteria of eye worm history and microfilaremia.

Results: Analysis of data from 1,232 individuals showed that occurrence of clinical and hematological findings differed significantly between the infection states. Eye worm positivity was associated with a wide range of clinical manifestations while microfilaremia by itself was not. Loa loa infection was associated with presence of eosinophilia and absolute eosinophil counts were associated with extent of microfilaremia (p-adj. = 0.012, ß-estimate:0.17[0.04-0.31]).

Conclusions: Loiasis is a complex disease, causing different disease manifestations in patients from endemic regions. The consequences for the affected individuals or populations as well as the pathophysiological consequences of correlating eosinophilia are largely unknown. High-quality research on loiasis should be fostered to improve patient care and understanding of the disease.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Frequencies of signs and symptoms…
Fig 1. Frequencies of signs and symptoms within the three loiasis infection states and in uninfected individuals as bar plots and adjusted p-values of inter group comparisons, if significant.
All intergroup comparisons are adjusted to sex, age and Mansonella PCR. * p-adj. <0.05; **p-adj. <0.01; *** p-adj. <0.001; * LN = No sign of loiasis infection; MF = detectable microfilaremia but no history of eye worm; EW = positive history of eye worm but no detectable microfilaria; EWMF = positive history of eye worm as well as detectable microfilaremia.
Fig 2
Fig 2
Distribution of hematological findings including median and interquartile range of hemoglobin (A), total white blood cell count (B), absolute (C) and relative eosinophil counts (D) within the four infection states. Adjusted p-values of intergroup comparisons are provided if <0.05. All intergroup comparisons are adjusted to sex, age and positivity of Mansonella PCR. * p-adj. <0.05; **p-adj. <0.01; *** p-adj. <0.001; LN = No sign of loiasis infection; MF = detectable microfilaremia but no history of eye worm; EW = positive history of eye worm but no detectable microfilaria; EWMF = positive history of eye worm as well as detectable microfilaremia.
Fig 3. Graphic presentation of the hematological…
Fig 3. Graphic presentation of the hematological and clinical findings within the study population.
3A is a diagram depicting the distribution and overlap of the diagnostic findings of history of eye worm, microfilaremia and eosinophilia in the study population (Eosinophilia data missing for 133 (10.8%) participants, see supporting information Table D). 3B depicts the distribution of the three mutually exclusive infection states in the same diagram based on diagnostic criteria. These include microfilaremic (MF), positive history of eye worm (EW), and individuals positive for both (EWMF). 3C displays the clinical outcome of eye worm positive loiasis and 3D the hematological outcome of microfilaremic loiasis in this schematic display. Note that these outcomes are not mutually exclusive, but overlap in individuals who are positive for both diagnostic criteria.

References

    1. Boussinesq M. Loiasis. Ann Trop Med Parasitol. 2006;100: 715–731. doi: 10.1179/136485906X112194
    1. Zouré HGM, Wanji S, Noma M, Amazigo UV, Diggle PJ, Tekle AH, et al.. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA). PLoS Negl Trop Dis. 2011;5: e1210. doi: 10.1371/journal.pntd.0001210
    1. Akue JP, Nkoghe D, Padilla C, Moussavou G, Moukana H, Mbou RA, et al.. Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon. PLOS Neglected Tropical Diseases. 2011;5: e1329. doi: 10.1371/journal.pntd.0001329
    1. Dupont A, Zue-N’dong J, Pinder M. Common occurrence of amicrofilaraemic Loa loa filariasis within the endemic region. Trans R Soc Trop Med Hyg. 1988;82: 730. doi: 10.1016/0035-9203(88)90218-0
    1. Pion SDS, Demanou M, Oudin B, Boussinesq M. Loiasis: the individual factors associated with the presence of microfilaraemia. Ann Trop Med Parasitol. 2005;99: 491–500. doi: 10.1179/136485905X51300
    1. Eyebe S, Sabbagh A, Pion SD, Nana-Djeunga HC, Kamgno J, Boussinesq M, et al.. Familial Aggregation and Heritability of Loa loa Microfilaremia. Clinical Infectious Diseases. 2018;66: 751–757. doi: 10.1093/cid/cix877
    1. Buell KG, Whittaker C, Chesnais CB, Jewell PD, Pion SDS, Walker M, et al.. Atypical clinical manifestations of loiasis and their relevance for endemic populations. Open Forum Infect Dis. 2019;6. doi: 10.1093/ofid/ofz417
    1. Herrick JA, Metenou S, Makiya MA, Taylar-Williams CA, Law MA, Klion AD, et al.. Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas. Clin Infect Dis. 2015;60: 55–63. doi: 10.1093/cid/ciu723
    1. Herrick JA, Makiya MA, Holland-Thomas N, Klion AD, Nutman TB. Infection-associated Immune Perturbations Resolve One Year Following Treatment for Loa loa. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa137
    1. Klion AD, Massougbodji A, Sadeler BC, Ottesen EA, Nutman TB. Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis. 1991;163: 1318–1325. doi: 10.1093/infdis/163.6.1318
    1. Nutman TB, Miller KD, Mulligan M, Ottesen EA. Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations. J Infect Dis. 1986;154: 10–18. doi: 10.1093/infdis/154.1.10
    1. Takougang I, Meli J, Lamlenn S, Tatah PN, Ntep M. Loiasis—a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon. Ann Trop Med Parasitol. 2007;101: 151–160. doi: 10.1179/136485907X154511
    1. Carme B, Mamboueni JP, Copin N, Noireau F. Clinical and biological study of Loa loa filariasis in Congolese. Am J Trop Med Hyg. 1989;41: 331–337.
    1. Pinder M. Loa loa—a neglected filaria. Parasitol Today (Regul Ed). 1988;4: 279–284.
    1. Bouyou Akotet MK, Owono-Medang M, Mawili-Mboumba DP, Moussavou-Boussougou MN, Nzenze Afène S, Kendjo E, et al.. The relationship between microfilaraemic and amicrofilaraemic loiasis involving co-infection with Mansonella perstans and clinical symptoms in an exposed population from Gabon. J Helminthol. 2016;90: 469–475. doi: 10.1017/S0022149X15000607
    1. Mischlinger J, Veletzky L, Tazemda-Kuitsouc GB, Pitzinger P, Matsegui PB, Gmeiner M, et al.. Behavioural and clinical predictors for Loiasis. J Glob Health. 2018;8: 010413. doi: 10.7189/jogh.08.010413
    1. Veletzky L, Mombo-Ngoma G, Ramharter M. The Supposedly Innocuous Eye Worm: Or, What Could Make You Put Chili in Your Eye? Am J Trop Med Hyg. 2021;105: 1448–1449. doi: 10.4269/ajtmh.21-0319
    1. Veletzky L, Hergeth J, Stelzl DR, Mischlinger J, Manego RZ, Mombo-Ngoma G, et al.. Burden of disease in Gabon caused by loiasis: a cross-sectional survey. Lancet Infect Dis. 2020. doi: 10.1016/S1473-3099(20)30256-5
    1. Chesnais CB, Takougang I, Paguélé M, Pion SD, Boussinesq M. Excess mortality associated with loiasis: a retrospective population-based cohort study. Lancet Infect Dis. 2017;17: 108–116. doi: 10.1016/S1473-3099(16)30405-4
    1. Sandri TL, Kreidenweiss A, Cavallo S, Weber D, Juhas S, Rodi M, et al.. Molecular epidemiology of Mansonella species in Gabon. J Infect Dis. 2020. doi: 10.1093/infdis/jiaa670
    1. Orihel TC, editor. Bench Aids for the diagnosis of filarial infections. Geneva: World Health Organization; 1997.
    1. Winkler S, Willheim M, Baier K, Aichelburg A, Kremsner PG, Graninger W. Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis. Am J Trop Med Hyg. 1999;60: 680–686. doi: 10.4269/ajtmh.1999.60.680
    1. Metzger WG, Mordmüller B. Loa loa-does it deserve to be neglected? Lancet Infect Dis. 2014;14: 353–357. doi: 10.1016/S1473-3099(13)70263-9
    1. Pion SD, Chesnais CB. Uncovering the burden of loiasis: first estimates from Gabon. The Lancet Infectious Diseases. 2020;0. doi: 10.1016/S1473-3099(20)30324-8
    1. Jacobsen KH, Andress BC, Bhagwat EA, Bryant CA, Chandrapu VR, Desmonts CG, et al.. A call for loiasis to be added to the WHO list of neglected tropical diseases. The Lancet Infectious Diseases. 2022;0. doi: 10.1016/S1473-3099(22)00064-0
    1. Akue JP. Loa loa Pathogenesis in Humans. Human Emerging and Re-emerging Infections. John Wiley & Sons, Ltd; 2015. pp. 441–452. doi: 10.1002/9781118644843.ch23
    1. Whittaker C, Walker M, Pion SDS, Chesnais CB, Boussinesq M, Basáñez M-G. The population biology and transmission dynamics of Loa loa. Trends Parasitol. 2018;34: 335–350. doi: 10.1016/j.pt.2017.12.003
    1. Bhalla D, Dumas M, Preux P-M. Neurological manifestations of filarial infections. Handb Clin Neurol. 2013;114: 235–242. doi: 10.1016/B978-0-444-53490-3.00018-2
    1. Gobbi F, Boussinesq M, Mascarello M, Angheben A, Gobbo M, Rossanese A, et al.. Loiasis with Peripheral Nerve Involvement and Spleen Lesions. The American Journal of Tropical Medicine and Hygiene. 2011;84: 733–737. doi: 10.4269/ajtmh.2011.10–0458
    1. Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol. 2004;113: 30–37. doi: 10.1016/j.jaci.2003.10.050
    1. Babu S, Nutman TB. Immune responses to helminth infection. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM, editors. Clinical Immunology (Fifth Edition). London: Content Repository Only!; 2019. pp. 437–447.e1. doi: 10.1016/B978-0-7020-6896-6.00031–4
    1. Andy JJ, Ogunowo PO, Akpan NA, Odigwe CO, Ekanem IA, Esin RA. Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Trop. 1998;69: 127–140. doi: 10.1016/s0001-706x(97)00125-3
    1. Wammes LJ, Hamid F, Wiria AE, Wibowo H, Sartono E, Maizels RM, et al.. Regulatory T cells in human lymphatic filariasis: stronger functional activity in microfilaremics. PLoS Negl Trop Dis. 2012;6: e1655. doi: 10.1371/journal.pntd.0001655
    1. Adjobimey T, Hoerauf A. Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation. Ann Trop Med Parasitol. 2010;104: 455–464. doi: 10.1179/136485910X12786389891407
    1. Allen JE, Adjei O, Bain O, Hoerauf A, Hoffmann WH, Makepeace BL, et al.. Of mice, cattle, and humans: the immunology and treatment of river blindness. PLoS Negl Trop Dis. 2008;2: e217. doi: 10.1371/journal.pntd.0000217
    1. Klion AD, Law MA, Riemenschneider W, McMaster ML, Brown MR, Horne M, et al.. Familial eosinophilia: a benign disorder? Blood. 2004;103: 4050–4055. doi: 10.1182/blood-2003-11-3850
    1. Tamarozzi F, Buonfrate D, Ricaboni D, Ursini T, Foti G, Gobbi F. Spleen nodules in Loa loa infection: re-emerging knowledge and future perspectives. The Lancet Infectious Diseases. 2022;0. doi: 10.1016/S1473-3099(21)00632-0
    1. Akue JP, Eyang-Assengone E-R, Dieki R. Loa loa infection detection using biomarkers: current perspectives. Res Rep Trop Med. 2018;9: 43–48. doi: 10.2147/RRTM.S132380
    1. Fink DL, Kamgno J, Nutman TB. Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis. 2011;5: e1299. doi: 10.1371/journal.pntd.0001299
    1. Akue JP, Devaney E, Wahl G, Moukana H. Expression of filarial-specific IgG subclasses under different transmission intensities in a region endemic for loiasis. Am J Trop Med Hyg. 2002;66: 245–250. doi: 10.4269/ajtmh.2002.66.245
    1. Van Hoegaerden M, Chabaud B, Akue JP, Ivanoff B. Filariasis due to Loa loa and Mansonella perstans: distribution in the region of Okondja, Haut-Ogooué Province, Gabon, with parasitological and serological follow-up over one year. Trans R Soc Trop Med Hyg. 1987;81: 441–446. doi: 10.1016/0035-9203(87)90163-5
    1. Takougang I, Meremikwu M, Wandji S, Yenshu EV, Aripko B, Lamlenn SB, et al.. Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ. 2002;80: 852–858.

Source: PubMed

3
購読する